Vermont advances bill letting unelected Health Commissioner decide which vaccines ctizens should receive
By Jon Fleetwood | February 19, 2026
The Vermont House of Representatives has passed House Bill 545, a sweeping law that grants the state’s unelected Health Commissioner the authority to issue official recommendations determining which vaccines children and adults in Vermont should receive, explicitly names influenza vaccines in statute—including future reformulations—and shields healthcare providers from civil liability for injuries caused by those injections.
The law also authorizes pharmacy technicians—personnel who historically served in support roles rather than frontline clinical injection roles—to administer influenza vaccines to children as young as five, dramatically expanding the range of individuals authorized under state law to deliver those shots.
You can see which representatives voted in favor of the bill here, with only nine voting against.
House Bill 545 is now advancing through the Vermont Senate, where it has already received favorable committee approval.
Taken together, the legislation embeds influenza vaccination directly into Vermont’s permanent statutory immunization infrastructure while placing vaccine recommendation authority in the hands of a single appointed official and protecting those administering the vaccines from lawsuits if harm occurs.
The bill’s passage comes as governments in the United States and internationally have poured billions of dollars into influenza pandemic preparedness, surveillance networks, and next-generation influenza vaccine development, with influenza repeatedly singled out in federal funding laws and global planning frameworks as a priority pandemic-capable virus.
It also comes as Kentucky Senator Rand Paul (R) has introduced federal legislation to strip vaccine manufacturers of their nationwide liability immunity, directly challenging the decades-old legal framework that shields the industry from civil lawsuits and reroutes injury claims into a federal compensation system.
This highlights a growing split between expanding liability protections for those administering vaccines at the state level and simultaneous federal efforts to remove liability protections for the manufacturers producing them.
Sorry, the comment form is closed at this time.
